Trisomy 13 is Associated with Poor Prognosis in Idiopathic Myelofibrosis with Myeloid Metaplasia

References

• Cervantes E, Pereira A., Esteve J., Rafel M., Cobo F., Roman C., Montserrat E. Identification of “short-lived” versus “long-lived” patients at presentation of idiopathic myelofibrosis. Br J Haematol 1997; 97: 635–640
   PubMed Web of Science ®Google Scholar
• Dupriez B., Morel P., Demory J. L., Lai J. L., Simon M., Plantier I., Bauters F. Prognostic factors in agno-genic myeloid metaplasia: A report on 195 cases with a new scoring system. Blood 1996; 88: 1013–1018
   PubMed Web of Science ®Google Scholar
• Visani G., Finelli C., Castelli U., Petti M. C., Ricci P., Vianelli N., Gianni L., Zuffa E., Spiriti A., Latagliata R., Pileri S., Magrini U., Gugliotta L., Morra E., Bernasconi C., Mandelli F., Tura S. Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients. Br J Haematol 1990; 75: 4–9
   PubMed Web of Science ®Google Scholar
• Reilly J. T., Snowden J. A., Spearing R. L., Fitzgerald P. M., Jones N., Watmore A., Potter A. Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: a study of 106 cases. Br J Haematol 1997; 98: 96–102
   PubMed Web of Science ®Google Scholar
• Demory J. L., Dupriez B., Fenaux P., Lai J. L., Beuscart R., Jouet J. P., Deminatti M., Bauters F. Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: a report on 47 cases. Blood. 1988; 72: 855–859
   PubMed Web of Science ®Google Scholar
• Ferrara F, Vicari L., Festa B., Di Noto R., Pane F., Sebas-Tio L., Cimino R. Trisomy 13 in a case of myelofibrosis with myeloid metaplasia in early blastic transformation. Haemarologica 1995; 80: 434–436
   PubMedGoogle Scholar
• Hsu L. Y., Greenberg M. L., Kohan S., Wittman R. Trisomy 13 in bone marrow cells in acute myelocytic leukemia and myelofibrosis. Clinical Genetics 1979; 15: 327–331
   PubMed Web of Science ®Google Scholar
• Schweizer D. Simultaneous fluorescent staining of R bands and specific hetemhromatic regions (DA-DAPI bands) in human chromosomes. Cytogenet Cell Genetics 1980; 27: 190–193
   PubMedGoogle Scholar
• Mitelman F. Guidelines for Cancer Cytogenet-ics. Supplement to an International System for Human Cytogenetic Nomenclature. Karger. Basel, Switzerland 1991, ISCN
   Google Scholar
• Drach J., Angerler J., Schuster J., Rothermundt C. A., Thal-Hammer R., Haas O. A., Jäger U., Fiegl M., Geissler K., Ludwig H., Huber H. Interphase fluorescence in situ hybridisation identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance. Blood 1995; 86: 3915–3921
   PubMed Web of Science ®Google Scholar
• Jack F. R., Summerfield G. P. Long term remission of acute myeloid leukaemia with trilineage myelodys-plasia treated solely with low dose cytarabine. Clin Lab Haematol 1994; 16: 197–200
   PubMedGoogle Scholar
• Kawano F., Nishimura Y., Tsukamoto A., Satoh M., San-Ada I., Shido T. Successful treatment with low dose Ara-C in de novo acute myeloid leukemia with trilineage myelodysplasia. Int J Hematol 1992; 55: 101–102
   PubMed Web of Science ®Google Scholar
• Kanamori H., Tanabe J., Koike T., Hashimoto Y., Mat-Suzaki M., Kitamura H., Motomura S., Mohri H., Ohkubo T. Successful treatment of low dose cytosine arabinoside for acute myelofibrosis with immature myeloblasts (AML-MO). Am J Hematol 1994; 46: 154–155
   PubMed Web of Science ®Google Scholar
• Whitehead S., Geary C. G. Low dose cytosine arabinoside to induce remission in acute myelofibrosis. Br J Haematol 1984; 58: 375–376
   PubMed Web of Science ®Google Scholar
• Reilly J. T., Dolan G. Proposed classification for the myelodysplasia/myelofibrosis syndromes. Br J Haematol 1991; 79: 653
   PubMed Web of Science ®Google Scholar
• Guenova M., Taskov H., Zechev J. CD4+ acute undifferentiated leukaemia, propably early monoblastic type, developing in a patient with myelodysplastic syndrome and bone marrow fibrosis. Leuk Lymphoma 1997; 26: 399–403
   PubMed Web of Science ®Google Scholar
• Lambertenghi-Deliliers G., Annaloro C., Oriani A., Soligo D. Myelodysplastic syndrome associated with bone marrow fibrosis. Leuk Lymphoma 1992; 8: 51–55
   PubMed Web of Science ®Google Scholar
• Martyre M. C. TGF-b˜ and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders. Leuk Lymphoma. 1995; 20: 39–44
   PubMed Web of Science ®Google Scholar
• Martyre M. C., Magdelenat H., Bryckaert H., Laine-Bidron C., Calvo F. Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-b˜ in patients with myelofibrosis with myeloid metaplasia. Br J Haematol 1991; 77: 80–86
   PubMed Web of Science ®Google Scholar
• Tefferi A., Silverstein M. N. Current perspective in agnogenic myeloid metaplasia. Leuk Lymphoma 1996; 22%(Suppl. 1)169–171
   PubMed Web of Science ®Google Scholar
• Kimura A., Kawaishi K., Nakata Y., Hyodo H., Kuramoto A., Satow Y. Leukemic transformation of primary myelofibrosis: immunophenotype, genotype and growth characteristics of blast cells. Leuk Lymphoma 1995; 19: 493–498
   PubMed Web of Science ®Google Scholar
• Thiele J., Kvasnicka H. M., Werden C., Zankovich R., Diehl V., Fischer R. Idiopathic primary oswmy-elofibrosis: a clinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact. Leuk Lymphoma 1996; 22: 303–317
   PubMed Web of Science ®Google Scholar
• Reilly J. T., Wilson G., Barnett D., Watmore A., Potter A. Karyotypic and ras gene mutational analysis in idiopathic myelofibrosis. Br J Haematol 1994; 88: 575–581
   PubMed Web of Science ®Google Scholar
• Wang J. C., Lang H. D., Lichter S., Weinstein M., Benn P. Cytogenetic studies of bone marrow fibroblasts cul-tered from patients with myelofibrosis and myeloid metaplasia. Br J Hmmarol 1992; 80: 184–188
   PubMed Web of Science ®Google Scholar
• Mertens F., Johansson B., Heim S., Kristofferson U., Mitelman F. Karyotypic patterns in chronic myeloproliferative disorders: report on 74 cases and review of the literature. Leukemia. 1991; 5: 214–220
   PubMed Web of Science ®Google Scholar
• Smadja N., Krulik M., de Gramont A., Sirinelli A., Bris-Saud P., Dray C., Audebert A. A., Debray J. Cytogenetic studies in twelve patients with primary myelofibrosis and myeloid metaplasia. Cancer Genet Cytogenet 1987; 24: 151–158
   PubMed Web of Science ®Google Scholar
• Miller J. B., Testa J. R., Lindgren V., Rowley J. D. The pattern and clinical significance of karyotypic abnormalities in patients with idiopathic and postpoly-cythemic myelofibrosis. Cancer 1985; 55: 582–591
   PubMed Web of Science ®Google Scholar
• Carbone P., Barbata G., Mirto S., Marceno R., Leone S., Granata G. Cytogenetic studies in five patients with myelofibrosis and myeloid metaplasia. Cancer Genet Cytogenet 1984; 12: 209–215
   PubMed Web of Science ®Google Scholar
• Borgstrom G. H., Knuutila S., Ruutu T., Pakkala A., Lahtinen R., de la Chapelle A. Abnormalities of chromosome 13 in myelofibrosis. Scad J Haematol 1984; 33: 15–21
   PubMedGoogle Scholar
• Besa E. C., Nowell P. C., Geller N. L., Gardner F. M. Analysis of the androgen response of 23 patients with agnogenic myeloid metaplasia: the value of chromosomal studies in prediccting response and survival. Cancer 1982; 49: 308–313
   PubMed Web of Science ®Google Scholar
• Nowell P., Jensen J., Gardner F., Murphy S., Chaganti R. S., German J. Chromosome studies in “preleu-kemia”. III. Myelofibrosis. Cancer 1976; 38: 1873–1881
   PubMed Web of Science ®Google Scholar
• Döhner H., Arthur D. C., Ball E. D., Sobol R. E., Davey F. R., Lawrence D., Gordon L., Patil S. R., Surana R. B., Testa J. R., Verma R. S., Schiffer C. A., Wurster-Hill D. H., Bloomfield C. D. Trisomy 13: A new recurring chromosome abnormality in acute leukemia. Blood 1990; 76: 1614–1621
   PubMed Web of Science ®Google Scholar
• Mehta A. B., Bin B. J., Fitchett M., Sha S., Secker-Walker L. M. Trisomy 13 and myeloid malignancy - characteristic blast cell morphology: a United Kingdom Cancer Cytogenetics Group survey. Br J Haematol 1998; 101: 749–752
   PubMed Web of Science ®Google Scholar